Literature DB >> 9420277

Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting.

P H Bednarek1, B J Lee, S Gandhi, E Lee, B Phillips.   

Abstract

The E6 and E7 genes of human papillomaviruses (HPVs) associated with anogenital cancers are largely responsible for the oncogenic activity of these viruses, and regulation of these genes has been intensively studied. Transcription of the E6 and E7 genes is controlled by the viral upstream regulatory region (URR). We have used in vivo footprinting to examine the occupancy by regulatory factors of the HPV type 18 (HPV18) URR enhancer and promoter in the cervical carcinoma cell lines HeLa and C4-II. While corroborating occupancy in vivo of all of the elements previously implicated in the transcriptional control of the HPV18 E6 and E7 genes by in vitro DNase I footprinting, gel retardation assays, and transfection studies, we also detect occupancy in vivo of several enhancer and promoter sequences which have not been previously identified as HPV18 URR regulatory elements. Our data suggest that the HPV18 enhancer and promoter are more densely occupied by DNA-binding proteins than previously thought and raise the possibility that additional, possibly novel factors contribute to transcription of the HPV18 early genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420277      PMCID: PMC109426     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes.

Authors:  F Thierry; G Spyrou; M Yaniv; P Howley
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18.

Authors:  H Romanczuk; L L Villa; R Schlegel; P M Howley
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1.

Authors:  J H Xiao; I Davidson; H Matthes; J M Garnier; P Chambon
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

4.  Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.

Authors:  T Chong; W K Chan; H U Bernard
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

5.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm.

Authors:  A P Cullen; R Reid; M Campion; A T Lörincz
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 6.  Human papillomaviruses in the pathogenesis of anogenital cancer.

Authors:  H zur Hausen
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

7.  Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1.

Authors:  F Hoppe-Seyler; K Butz; H zur Hausen
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells.

Authors:  D H Mack; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

9.  The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription.

Authors:  T Chong; D Apt; B Gloss; M Isa; H U Bernard
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Human papillomavirus type 16 and 18 gene expression in cervical neoplasias.

Authors:  M H Stoler; C R Rhodes; A Whitbeck; S M Wolinsky; L T Chow; T R Broker
Journal:  Hum Pathol       Date:  1992-02       Impact factor: 3.466

View more
  4 in total

1.  Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.

Authors:  Grant A Darnell; Toni M Antalis; Barbara R Rose; Andreas Suhrbier
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity.

Authors:  Isabelle Bouallaga; Sébastien Teissier; Moshe Yaniv; Françoise Thierry
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

3.  Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer.

Authors:  Edgar Grinstein; Peter Wernet; Peter J F Snijders; Frank Rösl; Inge Weinert; Wentao Jia; Regine Kraft; Christiane Schewe; Michael Schwabe; Steffen Hauptmann; Manfred Dietel; Chris J L M Meijer; Hans-Dieter Royer
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

4.  Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells.

Authors:  R A Shamanna; M Hoque; T Pe'ery; M B Mathews
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.